(Q46039009)

English

Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.

scientific article published on 3 May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

Mycobacterium tuberculosis

0 references

0 references

Tom H M Ottenhoff

10

object named as

Tom H M Ottenhoff

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

Kees L M C Franken

5

object named as

Kees L M C Franken

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

Krista E van Meijgaarden

4

object named as

Krista E van Meijgaarden

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

author name string

Maytal Bivas-Benita

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

May Young Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

Suzanne M Bal

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

Annemieke H Friggen

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

Hans E Junginger

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

Gerrit Borchard

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

Michèl R Klein

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

language of work or name

0 references

publication date

3 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

27

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

30

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

4010-4017

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Preclinical testing of new vaccines for tuberculosis: a comprehensive review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Advances in tuberculosis vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

The tuberculosis vaccine challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

How can immunology contribute to the control of tuberculosis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Tuberculosis: a problem with persistence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Vaccination against tuberculosis by DNA injection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

DNA vaccines for therapy of tuberculosis: where are we now?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Current progress of DNA vaccine studies in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Rational design of gene-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Current status of DNA vaccines and their route of administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Non-invasive pulmonary aerosol delivery in mice by the endotracheal route

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Intracellular DNA sensors in immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

A DNA vaccine against tuberculosis based on the 65 kDa heat-shock protein differentially activates human macrophages and dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Dendritic cell regulation of TH1-TH2 development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Vaccination with DNA vaccines encoding MPB70 or MPB83 or a MPB70 DNA prime-protein boost does not protect cattle against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Pulmonary DNA vaccination: concepts, possibilities and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Characterization of the memory/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette-Guérin or DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.033

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.04.033

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19389445

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46039009&oldid=2143317620"